The Clinical Operations and Research team at Vigil Neuro is responsible for designing and executing clinical trials that evaluate the safety and efficacy of innovative microglia-focused therapies. They collaborate across functions to ensure compliance with regulatory standards, manage trial logistics, and analyze clinical biomarker data, ultimately driving the development of precision-based treatments for neurodegenerative diseases. Their expertise in drug metabolism, clinical trial innovation, and biometrics supports the company's mission to enhance patient outcomes through rigorous scientific inquiry and operational excellence.